Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-24 @ 11:51 PM
NCT ID:
NCT00402051
Eligibility Criteria:
Inclusion Criteria:
* Cytologically and/or histologically confirmed NSCLC Stage IIIb or IV
* No previous systemic chemotherapy for this cancer
* At least one uni-dimensionally measurable lesion meeting Response Evaluation Criteria In Solid Tumors (RECIST) criteria
* Eastern Cooperative Oncology Group (ECOG) Performance status of 0 or 1 and adequate organ function
* Prior radiation therapy allowed but limited to \<25% of the patient's bone marrow
Exclusion Criteria:
* Serious concomitant systemic disorder or active infection
* Mild to moderate renal insufficiency, but unable to interrupt salicylates or other nonsteroidal anti-inflammatory drugs
* Symptomatic central nervous system (CNS) metastases requiring concurrent corticosteroid therapy
* Presence of clinically significant third-space fluid collections
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00402051
Study Brief:
Protocol Section:
NCT00402051